Sandbox
Revision as of 16:43, 27 February 2015 by Rossdonaldson1 (talk | contribs)
| Medication | Dose | Comments | Contraindications |
| Calcium-Channel Blockers | |||
| Diltiazem |
|
| |
| Beta-Blockers | |||
| Metoprolol |
|
|
|
| Esmolol | *Bolus 0.5 mg/kg over one minute, followed by 50 µg/kg/min *If, after 4min response is inadequate, re-bolus followed by infusion of 100 µg/kg/min *If, after 4min response is still inadequate, try final bolus followed by infusion of 150 µg/kg/min *If necessary, infusion can be increased to maximum of 200 µg/kg/min after another four minutes | *Use if unsure whether patient will tolerate a beta blocker since the duration of action is only 10 minutes | |
| Other | |||
| Digoxin | |||
| *0.25 mg IV q2hr up to 1.5 mg, then 0.125-0.25 mg PO or IV QD *Adjust dose in presence of renal failure, amiodarone, etc | *Consider as initial therapy for pts with LV dysfunction who: **Do not achieve rate control targets on beta blockers alone **Cannot tolerate addition of or increased doses of beta blocker due to decompensated CHF **Would have digoxin added anyway to improve CHF symptoms independent of A-fib *Consider as initial therapy in pts with severe hypotension *Consider as 2nd agent in pts in whom IV BB or IV CCB has failed to control their rate *May take up to 6-8 hours to work | ||
| Amiodarone | *Load 3-7 mg/kg IV over 30 min; then 1200 mg over 24hr via continuous infusion or in divided oral dosesKhan IA et al. Amiodarone for pharmacological cardioversion of recent-onset atrial fibrillation. Int J Cardiol. 2003 Jun;89(2-3):239-48. | *Consider for patients with decompensated heart failure or those with accessory pathways *2nd-line agent for chronic rate control when BBs and CCBs, alone, combined, or when used with digoxin, are ineffective |
- ↑ Short PM, Lipworth SI, Elder DH, Schembri S, Lipworth BJ. Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study. BMJ. 2011 May 10;342:d2549
- ↑ Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999 Jun 12;353(9169):2001-7Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II–DAVIT II). Am J Cardiol. 1990 Oct 1;66(10):779-85
